Beckman Coulter’s Bruce Wallace is one of the few executives in the molecular biology tools industry whose job responsibilities and job title specifically address the emerging systems-biology market.

Wallace, 54, is vice president and director of Beckman’s systems biology business center, a post he has held for one year after joining the Fullerton, Calif., company three years ago from Nanogen, where he was vice president for research and development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.